2 Top Biotech Stocks to Buy Right Now
The biotech sector has brought its share of big gains to investors' portfolios, from coronavirus success stories such as Moderna to long-established names like Biogen. Moderna, the maker of a top-selling coronavirus vaccine, has climbed more than 600% over the past two and a half years. Biogen has advanced 11,000% since its trading debut.
It's clear biotech companies make a great addition to a diversified portfolio. So, which players should you buy these days? Look for companies with a solid pipeline and strong revenue prospects ahead. And if they're already generating revenue, that's a huge plus. Let's check out two stocks to buy right now.
The bad news for AbbVie (NYSE: ABBV) is that its major blockbuster drug, the rheumatoid arthritis treatment Humira, will face competition in the U.S. as of next year. The good news is that the rest of AbbVie's immunology portfolio may eventually compensate for the loss.
Source Fool.com
